-transparent.png){kind=logo}
Intracarotid infusions of leukotriene C4 (LTC4) were used to open selectively the blood-brain barrier (BBB) in ischemic tissue after middle cerebral artery (MCA) occlusion in rats. BBB permeability was determined by quantitative autoradiography using [14C]aminoisobutyric acid. Seventy-two hours after MCA occlusion, LTC4 (4 micrograms total dose) infused into the carotid artery ipsilateral to the MCA occlusion selectively increased the unidirectional transfer constant for permeability Ki approximately threefold within core ischemic tissue and tissue adjacent ot the ischemic core. No effect on BBB permeability was seen within nonischemic brain tissue or in ischemic tissue after only 24 h after MCA occlusion. gamma-Glutamyl transpeptidase (gamma-GTP) activity was decreased in capillaries in ischemic tissue at 48 and 72 h after infarction, compared to high gamma-GTP in normal brain capillaries and moderate gamma-GTP in capillaries in the ischemic tissue at 24 h after infarction. These findings suggest that normal brain capillaries resist the vasogenic effects of LTC4. In contrast, LTC4 increases permeability in capillaries of ischemic tissue, where gamma-GTP is decreased. gamma-Glutamyl transpeptidase, an enzyme that inactivates LTC4 to LTD4 and LTE4 to LTF4, may act as an "enzymatic barrier" in normal brain capillaries to leukotrienes.
T Baba, and
K L Black, and
K Ikezaki, and
K N Chen, and
D P Becker
January 1990,
Acta neurochirurgica. Supplementum,
T Baba, and
K L Black, and
K Ikezaki, and
K N Chen, and
D P Becker
June 1990,
Journal of neurosurgery,
T Baba, and
K L Black, and
K Ikezaki, and
K N Chen, and
D P Becker
October 1994,
Brain research,
T Baba, and
K L Black, and
K Ikezaki, and
K N Chen, and
D P Becker
July 2000,
Acta pharmacologica Sinica,
T Baba, and
K L Black, and
K Ikezaki, and
K N Chen, and
D P Becker
January 1995,
Anticancer research,
T Baba, and
K L Black, and
K Ikezaki, and
K N Chen, and
D P Becker
January 1998,
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group,
T Baba, and
K L Black, and
K Ikezaki, and
K N Chen, and
D P Becker
April 1994,
Neurological research,
T Baba, and
K L Black, and
K Ikezaki, and
K N Chen, and
D P Becker
September 1998,
Neuroscience letters,
T Baba, and
K L Black, and
K Ikezaki, and
K N Chen, and
D P Becker
November 2001,
Experimental brain research,
T Baba, and
K L Black, and
K Ikezaki, and
K N Chen, and
D P Becker
February 1996,
Anti-cancer drugs,
